Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026 Ready to Announce with Confidence?
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope" or the "Company"), a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2026 (Q2 FY2026). The Company generated revenues of approximately $1.6 million during this period, with strong contributions from the development and delivery of Self-Driving Laboratories (SDL), with an adjusted EBITA loss of $0.7 million consistent with management's expectations. Year-to-date gross revenues increased to $4.3 million compared with $2.2 million in the same six-month period last year.
FINANCIAL HIGHLIGHTS OF THE FISCAL QUARTER ENDED FEBRUARY 28, 2026 (Q2 FY2026)
All values are represented in CAD.
OPERATIONAL HIGHLIGHTS
"Telescope has enjoyed tangible progress this quarter as we scale both our technology and our business," said Henry Dubina, Telescope CEO. "Delivering our second Self-Driving Laboratory to Pfizer, expanding internationally, demonstrating lithium battery recycling through our ReCRFT™ process, and expanding our lab infrastructure to grow the lithium portfolio all demonstrate technical proof and strong market demand across our platforms. These milestones position the Company to continue delivering technical and commercial targets throughout the fiscal year."
Readers are encouraged to review the full financial statements and accompanying management discussion and analysis for the quarter ended February 28 th, 2026, both of which are available under the profile for the Company on SEDAR+ ( www.sedarplus.ca).
About Telescope Innovations
Telescope is a chemical technology company developing intelligent automation technologies and scalable manufacturing processes for the pharmaceutical and chemical industry. The Company builds and deploys reaction sampling systems for real-time analysis, flexible robotic platforms, and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company's "Self-Driving Labs" are fully autonomous, physical AI platforms that plan, execute, and analyze experiments far more efficiently than traditional manual approaches. Bio-pharmaceutical, high value specialty chemical, and advanced materials companies utilize Telescope's products and services to accelerate the development and optimization of chemical processes, thereby cutting down time and costs from lab to market. For more information, please visit www.telescopeinnovations.com.
On behalf of the Board,
Telescope Innovations Corp.
Henry Dubina, Chief Executive Officer
E: henry.dubina@telescopeinn.com
778-262-1166
This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Telescope Innovations to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. These statements relate to future events or future performance and include, but are not limited to the Company's ability to continue delivering technical and commercial targets throughout the fiscal year. A number of factors could cause actual events, performance, or results to differ materially from what is projected in the forward-looking statements, including without limitation: technological risks and uncertainties; market acceptance of Telescope's technology; the Company's ability to retain key personnel; general economic conditions; and other risks detailed in the Company's public filings. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/292312
Source: Telescope Innovations Corp.
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Telescope Innovations Corp. or all companies in the Technology, Chemical, Pharmaceuticals industry.
Telescope Innovations Provides Financial Results of Second Fiscal Quarter 2026
2026-04-13 6:00 PM EDT
Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation
2026-03-23 8:00 AM EDT
Telescope Innovations and AGI SDA Launch Technology Development Collaboration
2026-03-16 8:00 AM EDT
Jan 30, 2026
To understand where public relations and investor communications are headed, we analyzed over 39,000 press releases distributed in 2025. The data is clear: success now depends on a careful balance between AI-readability and human trust. More than 50% of news activity on the TMX Newsfile network is now driven by AI bots from OpenAI and Microsoft. Yet these systems rely on human-verified facts to ground their answers. We have entered a “ zero-click ” reality, where Generative AI systems...
Economy, Business and Finance
Chemicals
Pharmaceutical
Science and Technology
Quarterly or Semiannual Financial Statement
Technology
Chemical
Pharmaceuticals